- Fund Type: Unit Trust
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
AXA Framlington Biotech Fund
+ Add to WatchlistFRABIOI:LN
88.41 GBp 1.02 1.17%As of 00:59:30 ET on 05/20/2013.
Snapshot for AXA Framlington Biotech Fund (FRABIOI)
| Year To Date: | +41.32% | 3-Month: | +23.85% | 3-Year: | +24.02% | 52-Week Range: | 57.33 - 90.41 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +10.70% | 1-Year: | +51.85% | 5-Year: | +21.23% | Beta vs NBI: | 0.80 |
Fund Profile & Information for FRABIOI
AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.
| Inception Date: | 11-26-2001 | Telephone: | 44-207-374-4100 |
|---|---|---|---|
| Managers: | LINDEN THOMSON / GEMMA GAME | ||
| Web Site: | www.axaframlington.com | ||
Fundamentals for FRABIOI
| NAV | (on 2013-05-20) 88.41 |
|---|---|
| Assets (M) | (on 2013-03-28) 127.99 |
| Fund Leveraged | N |
| Minimum Investment | 1,000.00 |
| Minimum Subsequent Investment | 100.00 |
Dividends for FRABIOI
| Dividend Type | Omitted |
|---|---|
| Dividend Frequency | Semi-Anl |
| Last Dividend Net | - |
| Dividend Yield (ttm) | - |
Fees & Expenses for FRABIOI
| Front Load | 5.50 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 1.75 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | 1.95 |
Top Fund Holdings for FRABIOI
Holding Data Unavailable.
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page